Metabolism and clinical assessment of L-dopa in parkinsonism.
D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage* / Q000009:adverse effects / Q000134:cerebrospinal fluid; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000134:cerebrospinal fluid / Q000188:drug therapy* / Q000378:metabolism; D010648:Phenylacetates / Q000134:cerebrospinal fluid; D014642:Vanilmandelic Acid / Q000134:cerebrospinal fluid
D010648:Phenylacetates; D014642:Vanilmandelic Acid; D004295:Dihydroxyphenylalanine